|
|
|
front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |review |
 |
If you break down
these patients by genotype, more than ¾ of patients achieve sustained
eradication of viral replication in the PEG + RBV group. Even the genotype 1
patients are close to the 50% SVR rates here. Remarkable progress over a
decade. From a single digit response rate to well over 50% cure rates! Fried MW et al. NEJM 2002 |